Dr Gunson and Dr Helen Dodsworth wrote "Fifty Years of Blood Transfusion" published in Transfusion Medicine which outlined the history of transfusion medicine in England and Wales. Read more about Dr Gunson and Dr Helen Dodsworth wrote "Fifty Years of Blood Transfusion" published in Transfusion Medicine which outlined the history of transfusion medicine in England and Wales.
A letter from the SHHD to Dr Maycock addressed the question of how much plasma the Blood Products Unit in Edinburgh would fractionate for England and Wales. Read more about A letter from the SHHD to Dr Maycock addressed the question of how much plasma the Blood Products Unit in Edinburgh would fractionate for England and Wales.
The minutes of the meeting of the Joint Steering Committee on Blood Products Production recorded that planning to extend BPL had commenced in 1962, however building had only commenced in 1969. The extension of BPL had operated at capacity from April 1972, and the original buildings were also being modernised with the expectation they would be completed by August 1973. Read more about The minutes of the meeting of the Joint Steering Committee on Blood Products Production recorded that planning to extend BPL had commenced in 1962, however building had only commenced in 1969. The extension of BPL had operated at capacity from April 1972, and the original buildings were also being modernised with the expectation they would be completed by August 1973.
In an article on "The Use of Human Anti-haemophilic Globulin (Fraction I-O) in Haemophilia A and in von Willebrand's Disease" published in Acta Haematologica, the development of antihaemophilic globulins (AHG) was reported which had treated 59 patients by 1959 in Sweden. Read more about In an article on "The Use of Human Anti-haemophilic Globulin (Fraction I-O) in Haemophilia A and in von Willebrand's Disease" published in Acta Haematologica, the development of antihaemophilic globulins (AHG) was reported which had treated 59 patients by 1959 in Sweden.
An article titled "A Concentrate of Human Antihaemophilic Factor - its use in six cases of haemophilia" published in The Lancet reported that they had developed antihaemophilic fraction ("AHF") which would enable clotting and had been used with success in six cases. Read more about An article titled "A Concentrate of Human Antihaemophilic Factor - its use in six cases of haemophilia" published in The Lancet reported that they had developed antihaemophilic fraction ("AHF") which would enable clotting and had been used with success in six cases.
An article "Red Cell Banking and the Production of a Factor VIII Concentrate" published in Vox Sanguinis demonstrated that by 1960, the Blood Products Unit in Edinburgh was fractionating plasma from 1,425 donors and investigating red cell concentrates to make full use of the donated blood. Read more about An article "Red Cell Banking and the Production of a Factor VIII Concentrate" published in Vox Sanguinis demonstrated that by 1960, the Blood Products Unit in Edinburgh was fractionating plasma from 1,425 donors and investigating red cell concentrates to make full use of the donated blood.
A product information sheet for the Scottish achievement recorded that it had ten times as much Factor 8 activity as fresh frozen plasma, and that "A similar fraction is prepared by ether fractionation (Kekwick)." Read more about A product information sheet for the Scottish achievement recorded that it had ten times as much Factor 8 activity as fresh frozen plasma, and that "A similar fraction is prepared by ether fractionation (Kekwick)."
In a letter to Dr Rosemary Biggs, Dr Cumming noted that there was no valid reason for a shortage of "coagulation factor" products, and that recent results from frozen plasma used in the production of concentrate meant that cryoprecipitate use would decline as centralised production by other methods was feasible. Read more about In a letter to Dr Rosemary Biggs, Dr Cumming noted that there was no valid reason for a shortage of "coagulation factor" products, and that recent results from frozen plasma used in the production of concentrate meant that cryoprecipitate use would decline as centralised production by other methods was feasible.
In a Department of Health report, it was concluded that very few countries were capable of completely satisfying their blood needs (ie becoming self-sufficient) without acquiring a proportion of blood from paid donors. Read more about In a Department of Health report, it was concluded that very few countries were capable of completely satisfying their blood needs (ie becoming self-sufficient) without acquiring a proportion of blood from paid donors.
In The Voluntary Blood Donor, Dr Cumming noted that the inadequacies that existed in modern developed countries were entirely the fault of the organisation of the service, and that forward planning was important for a successful voluntary blood donor system. Read more about In The Voluntary Blood Donor, Dr Cumming noted that the inadequacies that existed in modern developed countries were entirely the fault of the organisation of the service, and that forward planning was important for a successful voluntary blood donor system.